144 related articles for article (PubMed ID: 12856174)
1. Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A.
Yamada T; Tsurumi H; Kasahara S; Hara T; Sawada M; Moriwaki H
J Cancer Res Clin Oncol; 2003 Aug; 129(8):485-91. PubMed ID: 12856174
[TBL] [Abstract][Full Text] [Related]
2. [Cyclosporine A based therapy for myelodysplastic syndrome].
Li ZL; Gong M; Xu SH; Huang FZ; Chen YR; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):867-70. PubMed ID: 16277860
[TBL] [Abstract][Full Text] [Related]
3. [A preliminary report on treatment of myelodysplastic syndrome with cyclosporin a and androgen].
Wang JW; Ning F; Liu XD; Lou JX; Chen P; Liu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):855-7. PubMed ID: 15631678
[TBL] [Abstract][Full Text] [Related]
4. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F
Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602
[TBL] [Abstract][Full Text] [Related]
5. [Application of cyclosporine A in myelodysplastic syndrome--review].
Guan M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):678-80. PubMed ID: 14706160
[TBL] [Abstract][Full Text] [Related]
6. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
Takanashi M; Kadono Y; Tabata Y; Hibi S
Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
[TBL] [Abstract][Full Text] [Related]
7. Selective blast cell reduction in elderly patients with acute myeloid leukemia secondary to myelodysplastic syndrome treated with methylprednisolone.
Suzuki K; Ohishi K; Sekine T; Masuya M; Katayama N
Int J Hematol; 2007 May; 85(4):344-9. PubMed ID: 17483080
[TBL] [Abstract][Full Text] [Related]
8. [Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
Chen SC; Jiang B; Da WM; Gong M; Guan M
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2711-5. PubMed ID: 17199984
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic Syndrome.
Haider M; Al Ali N; Padron E; Epling-Burnette P; Lancet J; List A; Komrokji R
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S44-8. PubMed ID: 27521323
[TBL] [Abstract][Full Text] [Related]
10. [Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome].
Kokhno AV; Parovichnikova EN; Mikhaĭlova EA; Ustinova EN; Kaplanskaia IB; Dvirnyk VN; Ol'shanskaia IuV; Domracheva EV; Savchenko VG
Ter Arkh; 2010; 82(8):48-53. PubMed ID: 20873246
[TBL] [Abstract][Full Text] [Related]
11. [Hematologic response predictor factors in adults with myelodysplastic syndromes (SMD) treated with cyclosporin A (CSA)].
Zamora-Pérez E; López-Karpovitch X
Gac Med Mex; 2015; 151(3):345-53. PubMed ID: 26089271
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan.
Shimamoto T; Tohyama K; Okamoto T; Uchiyama T; Mori H; Tomonaga M; Asano Y; Niho Y; Teramura M; Mizoguchi H; Omine M; Ohyashiki K
Leuk Res; 2003 Sep; 27(9):783-8. PubMed ID: 12804635
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
[TBL] [Abstract][Full Text] [Related]
15. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
Yazji S; Giles FJ; Tsimberidou AM; Estey EH; Kantarjian HM; O'Brien SA; Kurzrock R
Leukemia; 2003 Nov; 17(11):2101-6. PubMed ID: 12931212
[TBL] [Abstract][Full Text] [Related]
16. Immunosupressive treatment with cyclosporin-A for a patient with hypoplastic myelodisplastic syndrome: a case report.
Pavkovic M; Jovanovic R; Petrusevska G; Cevreska L; Stojanovic A
Prilozi; 2011; 32(1):313-21. PubMed ID: 21822198
[TBL] [Abstract][Full Text] [Related]
17. Hypocellular myelodysplastic syndromes: clinical and biological significance.
Marisavljevic D; Cemerikic V; Rolovic Z; Boskovic D; Colovic M
Med Oncol; 2005; 22(2):169-75. PubMed ID: 15965280
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid.
Inase N; Sawada M; Ohtani Y; Miyake S; Isogai S; Sakashita H; Miyazaki Y; Yoshizawa Y
Intern Med; 2003 Jul; 42(7):565-70. PubMed ID: 12879947
[TBL] [Abstract][Full Text] [Related]
19. Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome.
Berer A; Ohler L; Simonitsch I; Thalhammer R; Lechner K; Geissler K
Wien Klin Wochenschr; 1999 Oct; 111(19):815-8. PubMed ID: 10568013
[TBL] [Abstract][Full Text] [Related]
20. Hypoplastic myelodysplastic syndrome transformed in acute myeloid leukemia after androgens and cyclosporin. A treatment.
Gologan R; Ostroveanu D; Dobrea C; Gioadă L
Rom J Intern Med; 2003; 41(4):447-55. PubMed ID: 15526527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]